• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

就组织学变化、转氨酶正常化及丙型肝炎病毒RNA血清学转换而言,α干扰素治疗慢性丙型肝炎的长期疗效。

Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion.

作者信息

Hosoda K, Yokosuka O, Kato N, Ito Y, Ohto M, Omata M

机构信息

First Department of Medicine, Chiba University School of Medicine, Japan.

出版信息

Gastroenterol Jpn. 1993 May;28 Suppl 5:115-7. doi: 10.1007/BF02989220.

DOI:10.1007/BF02989220
PMID:8395437
Abstract

To assess the effects of interferon treatment on chronic hepatitis C, histological changes long after treatment were compared with normalization of aminotransferases and seroconversion of hepatitis C virus RNA. Twenty one histologically proven chronic hepatitis C patients received alpha-interferon, 3 million units 3 times weekly for 12 months. Hepatitis C virus RNA was detected by reverse transcription/polymerase chain reaction method. Follow-up liver biopsies were performed 3 to 5 years after treatment. Fourteen of 21 (67%) patients showed normal aminotransferases for 3 to 5 years after treatment. HCV RNA seroconversion was observed in 12 of these patients. These responders showed improvement in histological activity indices and in histological findings. Two patients improved from chronic active hepatitis 2a to nonspecific changes, 1 from chronic active hepatitis 2a to portal fibrosis, 1 from chronic active hepatitis 2a to chronic persistent hepatitis and 1 from chronic active hepatitis 2b to chronic persistent hepatitis. Histological improvement of the liver correlated well with normalization of aminotransferases and seroconversion of hepatitis C virus RNA. These data indicate that complete histological resolution of chronic hepatitis C can be achieved by elimination of the virus with interferon treatment.

摘要

为评估干扰素治疗对慢性丙型肝炎的影响,将治疗后很长一段时间的组织学变化与转氨酶正常化及丙型肝炎病毒RNA血清学转换进行了比较。21例经组织学证实的慢性丙型肝炎患者接受了α干扰素治疗,剂量为300万单位,每周3次,共12个月。采用逆转录/聚合酶链反应法检测丙型肝炎病毒RNA。治疗后3至5年进行随访肝活检。21例患者中有14例(67%)在治疗后3至5年转氨酶正常。其中12例患者出现HCV RNA血清学转换。这些应答者的组织学活动指数和组织学表现均有改善。2例患者从慢性活动性肝炎2a改善为非特异性改变,1例从慢性活动性肝炎2a改善为门脉纤维化,1例从慢性活动性肝炎2a改善为慢性持续性肝炎,1例从慢性活动性肝炎2b改善为慢性持续性肝炎。肝脏组织学改善与转氨酶正常化及丙型肝炎病毒RNA血清学转换密切相关。这些数据表明,通过干扰素治疗清除病毒可实现慢性丙型肝炎组织学的完全缓解。

相似文献

1
Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion.就组织学变化、转氨酶正常化及丙型肝炎病毒RNA血清学转换而言,α干扰素治疗慢性丙型肝炎的长期疗效。
Gastroenterol Jpn. 1993 May;28 Suppl 5:115-7. doi: 10.1007/BF02989220.
2
Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
J Med Virol. 1993 Sep;41(1):65-70. doi: 10.1002/jmv.1890410114.
3
Long-term prognosis of chronic hepatitis C after treatment with interferon alpha 2b and characterization of incomplete responders.α-干扰素2b治疗慢性丙型肝炎后的长期预后及无应答者的特征分析
Am J Gastroenterol. 1996 Oct;91(10):2144-9.
4
Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.
Liver. 1994 Aug;14(4):169-74. doi: 10.1111/j.1600-0676.1994.tb00070.x.
5
Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.肝移植后丙型肝炎病毒感染的α干扰素治疗
Hepatology. 1994 Oct;20(4 Pt 1):773-9. doi: 10.1002/hep.1840200402.
6
Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.慢性丙型肝炎患者血清丙型肝炎病毒RNA滴度的变化及对干扰素治疗的反应
Dig Dis Sci. 1994 Oct;39(10):2244-9. doi: 10.1007/BF02090379.
7
Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.通过外周血单个核细胞中的丙型肝炎病毒RNA预测α干扰素治疗后的复发情况。
J Med Virol. 1995 Jul;46(3):265-8. doi: 10.1002/jmv.1890460317.
8
Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.
J Gastroenterol Hepatol. 1997 Jan;12(1):58-61. doi: 10.1111/j.1440-1746.1997.tb00347.x.
9
Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response.血友病患者慢性丙型肝炎感染的干扰素治疗——病毒载量、基因型和肝脏病理对疗效的影响
Blood. 1996 Mar 1;87(5):1704-9.
10
Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.用于预测慢性丙型肝炎患者对干扰素反应的丙型肝炎病毒基因型和滴度
J Med Virol. 1994 Mar;42(3):299-305. doi: 10.1002/jmv.1890420318.

引用本文的文献

1
The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment.抗病毒治疗丙型肝炎病毒对肝细胞癌治疗后患者生存的影响。
Intern Med. 2022;61(18):2721-2729. doi: 10.2169/internalmedicine.8456-21. Epub 2022 Sep 15.
2
Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection.预测 HCV 感染 DAA 治疗后 HCC 的极早期发生。
Hepatol Int. 2018 Nov;12(6):523-530. doi: 10.1007/s12072-018-9895-5. Epub 2018 Sep 21.
3
Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.

本文引用的文献

1
Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.通过丙型肝炎病毒RNA的灵敏聚合酶链反应分析评估长期干扰素治疗慢性肝病的疗效。
Gut. 1995 Nov;37(5):721-6. doi: 10.1136/gut.37.5.721.
2
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.一种用于评估无症状慢性活动性肝炎组织学活性的数值评分系统的制定与应用。
Hepatology. 1981 Sep-Oct;1(5):431-5. doi: 10.1002/hep.1840010511.
3
A classification of chronic hepatitis.
干扰素α-2a。其药理学特性及在病毒性肝炎治疗中的应用综述。
Drugs. 1995 Nov;50(5):873-96. doi: 10.2165/00003495-199550050-00007.
慢性肝炎的一种分类
Lancet. 1968 Sep 14;2(7568):626-8. doi: 10.1016/s0140-6736(68)90710-1.
4
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.用重组人α干扰素治疗慢性非甲非乙型肝炎。初步报告。
N Engl J Med. 1986 Dec 18;315(25):1575-8. doi: 10.1056/NEJM198612183152503.
5
Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.重组干扰素α治疗慢性丙型肝炎。一项随机、双盲、安慰剂对照试验。
N Engl J Med. 1989 Nov 30;321(22):1506-10. doi: 10.1056/NEJM198911303212204.
6
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.重组干扰素α治疗慢性丙型肝炎。一项多中心随机对照试验。
N Engl J Med. 1989 Nov 30;321(22):1501-6. doi: 10.1056/NEJM198911303212203.
7
Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.用重组白细胞干扰素α治疗慢性非甲非乙型肝炎时肝脏的组织学变化。与慢性乙型肝炎组织学变化的比较。
Dig Dis Sci. 1989 Mar;34(3):330-7. doi: 10.1007/BF01536251.
8
Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy.通过γ球蛋白替代疗法传播的非甲非乙型肝炎的α干扰素治疗。
Lancet. 1987 Mar 7;1(8532):539-41. doi: 10.1016/s0140-6736(87)90178-4.
9
Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.1或3百万单位α-2b干扰素与安慰剂治疗慢性非甲非乙型肝炎患者的比较。
Gastroenterology. 1991 Aug;101(2):497-502. doi: 10.1016/0016-5085(91)90030-o.
10
Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.重组α干扰素治疗慢性非甲非乙型肝炎八周疗程的随机、双盲、安慰剂对照试验
Dig Dis Sci. 1991 Sep;36(9):1217-22. doi: 10.1007/BF01307512.